TJX Companies (TJX) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
29 May, 2026Executive summary
Q1 FY27 net sales rose 9% to $14.3 billion, with consolidated comp sales up 6% and all divisions showing strong growth.
Diluted EPS increased 29% to $1.19, and net income reached $1.3 billion, up from $1.0 billion in the prior year.
Pre-tax profit margin improved to 12.0%, up 1.7 percentage points year-over-year, driven by higher merchandise margin and expense leverage.
$1.1 billion was returned to shareholders via share repurchases and dividends in Q1.
Initiatives in marketing, merchandising, and store experience are driving customer growth and market share gains.
Financial highlights
Net sales: $14.3 billion, up 9% year-over-year; net income: $1.3 billion, up from $1.0 billion.
Gross profit margin improved to 31.3%, up 1.8 percentage points year-over-year.
SG&A expenses were 19.5% of sales, a slight increase from 19.4% last year.
Operating cash flow was $1.1 billion, up from $394 million year-over-year.
Inventory was up 8% overall and 7% per store, totaling $7.7 billion.
Outlook and guidance
FY27 comparable sales growth outlook raised to 3%-4%; consolidated sales guidance raised to $63.2-$63.7 billion, up 5%-6%.
Full-year pre-tax profit margin guided at 11.9%-12.0%; gross margin 31.2%-31.3%.
Full-year diluted EPS raised to $5.08-$5.15, a 7%-9% increase year-over-year.
Share buyback guidance increased to $2.75-$3.0 billion for FY27.
Q2 FY27 guidance: comparable sales up 2%-3%, pretax profit margin 11.4%-11.5%, diluted EPS $1.15-$1.17.
Latest events from TJX Companies
- Record sales, strong shareholder returns, and robust governance highlight this year's proxy.TJX
Proxy filing30 Apr 2026 - Key votes include board elections, auditor ratification, and executive pay approval for 2026.TJX
Proxy filing30 Apr 2026 - Record sales and profit growth, margin gains, and robust outlook with higher shareholder returns.TJX
Q4 202625 Feb 2026 - Q2 sales and profit margins exceeded expectations; FY25 guidance and global investments increased.TJX
Q2 202523 Jan 2026 - Q3 net sales up 6% to $14.1B, EPS $1.14, with raised outlook and global expansion.TJX
Q3 202513 Jan 2026 - Sales, profitability, and EPS surpassed expectations, with strong growth and expansion plans.TJX
Q4 20257 Jan 2026 - Q3 FY26 sales up 7%, EPS up 12% to $1.28, and $1.1B returned to shareholders.TJX
Q3 20262 Dec 2025 - FY25 saw robust growth, strong returns, and enhanced ESG initiatives, with all Board proposals recommended for approval.TJX
Proxy Filing1 Dec 2025 - Key votes include board elections, auditor ratification, and executive pay approval.TJX
Proxy Filing1 Dec 2025